Alexander Tokman - Microvision CEO and President and Director
| MVIS Stock | USD 1.40 0.06 4.11% |
CEO
Mr. Alexander Tokman is President of Microvision Inc. Mr. Tokman has served as President, Chief Executive Officer and a director of MicroVision since January 2006. Mr. Tokman served as MicroVisions President and Chief Operating Officer from July 2005 to January 2006. Mr. Tokman, a former GE executive, joined MicroVision after a10year tenure at GE Healthcare, a subsidiary of General Electric, where he led several global businesses, most recently as General Manager of its Global Molecular Imaging and Radiopharmacy multitechnology business unit from 2003 to 2005. Prior to that, between 1995 and 2003, Mr. Tokman served in various crossfunctional and crossbusiness leadership roles at GE where he led the definition and commercialization of several medical modalities product segments including PETCT, which added over 500 million of revenue growth to the company within the first three years of its commercial introduction. Mr. Tokman is a certified Six Sigma and Design for Six Sigma Black Belt and Master Black Belt and as one of GEs Six Sigma pioneers, he drove the quality culture change across GE Healthcare in the late 1990s. From November 1989 to March 1995 Mr. Tokman served as new technologies programs lead and a head of IRD office at Tracor Applied Sciences a subsidiary of then Tracor, Inc since 2017.
| Age | 54 |
| Tenure | 7 years |
| Address | 18390 NE 68th Street, Redmond, WA, United States, 98052 |
| Phone | 425 936 6847 |
| Web | https://www.microvision.com |
Alexander Tokman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Alexander Tokman against Microvision stock is an integral part of due diligence when investing in Microvision. Alexander Tokman insider activity provides valuable insight into whether Microvision is net buyers or sellers over its current business cycle. Note, Microvision insiders must abide by specific rules, including filing SEC forms every time they buy or sell Microvision'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Alexander Tokman over a month ago Acquisition by Alexander Tokman of 600 shares of ENDRA Life subject to Rule 16b-3 |
Microvision Management Efficiency
The company has return on total asset (ROA) of (0.4543) % which means that it has lost $0.4543 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.893) %, meaning that it created substantial loss on money invested by shareholders. Microvision's management efficiency ratios could be used to measure how well Microvision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.77 in 2024. Return On Capital Employed is likely to drop to -0.86 in 2024. At this time, Microvision's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 45 M in 2024, whereas Return On Tangible Assets are likely to drop (0.77) in 2024.Similar Executives
| Found 1 records | CEO Age | ||
| Gerald Colella | MKS Instruments | 59 | |
Management Performance
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.45 |
Microvision Leadership Team
Elected by the shareholders, the Microvision's board of directors comprises two types of representatives: Microvision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microvision. The board's role is to monitor Microvision's management team and ensure that shareholders' interests are well served. Microvision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microvision's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeanette Horan, Independent Director | ||
| Thomas Walker, Director | ||
| David Westgor, VP, General Counsel and Secretary | ||
| Stephen Holt, CFO and Chief Accounting Officer | ||
| Sumit Sharma, CEO Director | ||
| Dawn Goetter, IR Contact Officer | ||
| Simon Biddiscombe, Director | ||
| Brian Turner, Chairman of the Board, Lead Independent Director | ||
| Yalon Farhi, Director | ||
| Drew Markham, Secretary Operations | ||
| Dale Zimmerman, VP of RandD | ||
| Richard Cowell, Independent Director | ||
| Perry Mulligan, Independent Director | ||
| James Johnston, Controller | ||
| Alexander Tokman, CEO and President and Director | ||
| Slade Gorton, Independent Director | ||
| Anubhav Verma, CFO VP | ||
| Bernee Strom, Director | ||
| Robert Carlile, Director | ||
| Lindsey Stibbard, Paralegal |
Microvision Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microvision a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.90) % | ||||
| Current Valuation | 214.63 M | ||||
| Shares Outstanding | 195.27 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 32.45 % | ||||
| Number Of Shares Shorted | 47.73 M | ||||
| Price To Earning | (6.80) X | ||||
| Price To Book | 3.27 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microvision. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Microvision Stock please use our How to Invest in Microvision guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Microvision Stock analysis
When running Microvision's price analysis, check to measure Microvision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microvision is operating at the current time. Most of Microvision's value examination focuses on studying past and present price action to predict the probability of Microvision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microvision's price. Additionally, you may evaluate how the addition of Microvision to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Microvision's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microvision. If investors know Microvision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microvision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share 0.04 | Quarterly Revenue Growth 0.048 | Return On Assets (0.45) | Return On Equity (0.89) |
The market value of Microvision is measured differently than its book value, which is the value of Microvision that is recorded on the company's balance sheet. Investors also form their own opinion of Microvision's value that differs from its market value or its book value, called intrinsic value, which is Microvision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microvision's market value can be influenced by many factors that don't directly affect Microvision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microvision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microvision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microvision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.